Cargando…

A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

In this study, we showed that a codon optimized version of the spike (S) protein of SARS-CoV-2 can migrate to the cell membrane. However, efficient production of Moloney murine leukemia (MLV) infectious viral particles was only achieved with stable expression of a shorter S version in C-terminal (ΔS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Sylvie, Ghani, Karim, de Campos-Lima, Pedro O., Caruso, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817443/ https://www.ncbi.nlm.nih.gov/pubmed/33482242 http://dx.doi.org/10.1016/j.virusres.2021.198305

Ejemplares similares

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
por: Salazar-García, Marcela, et al.
Publicado: (2022)

Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of Sars Coronavirus Spike Protein
por: Fukushi, Shuetsu, et al.
Publicado: (2006)

Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein
por: Johnson, Marc C., et al.
Publicado: (2020)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
por: Lin, Han-Xin, et al.
Publicado: (2011)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Lei, Changhai, et al.
Publicado: (2020)

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
por: Hsieh, Miao-Hsi, et al.
Publicado: (2021)

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation
por: Lee, Se Yeong, et al.
Publicado: (2022)

Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
por: Uppal, Sheetal, et al.
Publicado: (2023)

Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
por: Tandon, Ritesh, et al.
Publicado: (2020)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
por: Grehan, K., et al.
Publicado: (2015)

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus
por: Chan, C.M., et al.
Publicado: (2009)

Comparison of lentiviruses pseudotyped with S proteins from coronaviruses and cell tropisms of porcine coronaviruses
por: Wang, Jingjing, et al.
Publicado: (2016)

Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy
por: Cottin, Sylvine, et al.
Publicado: (2010)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

The Use of Retroviral Pseudotypes for the Measurement of Antibody Responses to SARS Coronavirus
por: Temperton, Nigel James
Publicado: (2009)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
por: Alkhaldi, Soha Y., et al.
Publicado: (2023)

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus
por: Wanitchang, Asawin, et al.
Publicado: (2018)

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
por: Sampson, Alexander Thomas, et al.
Publicado: (2021)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019)

GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
por: Yeh, Hsin, et al.
Publicado: (2022)

A Dominant-Negative Approach That Prevents Diphthamide Formation Confers Resistance to Pseudomonas Exotoxin A and Diphtheria Toxin
por: Roy, Vincent, et al.
Publicado: (2010)

A novel hamster model of SARS-CoV-2 respiratory infection using a pseudotyped virus
por: Yamada, Hiroshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pg2bgou3nss3u5f3g4t5gtpjq0